PUBLICATIONS

Covid19 Publications

Carr, E. J. et al. (2021) Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet, 398(10305), pp. 1038-1041. (doi: 10.1016/S0140-6736(21)01854-7) (PMID:34391504) (PMCID:PMC8360704)

Burton, J. K. , McMinn, M. , Vaughan, J. E., Fleuriot, J. and Guthrie, B. (2021) Care-home outbreaks of COVID-19 in Scotland March to May 2020: national linked data cohort analysis. Age and Ageing, 50(5), pp. 1482-1492. (doi: 10.1093/ageing/afab099) (PMID:33963849) (PMCID:PMC8136021)

Moothadeth, A., Waqar, S., Ghouri, N. , Iqbal, Z., Alam, J., Ahmed, S. and Abbas, S. Z. (2020) Fasting during Ramadan and the COVID-19 pandemic. Occupational Medicine, 70(5), pp. 306-308. (doi: 10.1093/occmed/kqaa103) (PMID:32428236) (PMCID:PMC7313800)

Qin, J.-J. et al. (2020) Redefining cardiac biomarkers in predicting mortality and adverse outcomes of inpatients with COVID-19. Hypertension, 76(4), pp. 1104-1112. (doi: 10.1161/HYPERTENSIONAHA.120.15528) (PMID:32673499) (PMCID:PMC7375179)

Waqar, S. and Ghouri, N. (2020) Managing Ramadan queries in COVID-19. BJGP Open, 4(2), bjgpopen20X101097. (doi: 10.3399/bjgpopen20X101097) (PMID:32423895) (PMCID:PMC7330224)

Gaudino, M., Arvind, V., Hameed, I., Di Franco, A., Spadaccio, C., Bhatt, D. L. and Bagiella, E. (2020) Effects of the COVID-19 pandemic on active non-COVID clinical trials. Journal of the American College of Cardiology, 76(13), pp. 1605-1606. (doi: 10.1016/j.jacc.2020.07.051) (PMID:32745501)

Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, 113(4), e24217. (doi: 10.1002/pep2.24217) (PMID:33615115) (PMCID:PMC7883042)

Burton, J. K. et al. (2021) Impact of COVID-19 on care-home mortality and life expectancy in Scotland. Age and Ageing, 50(4), pp. 1029-1037. (doi: 10.1093/ageing/afab080) (PMID:33914870) (PMCID:PMC8135527)

Sykes, R. , Morrow, A. and Mangion, K. (2021) The Janus of COVID-19: from registry data to prospective studies. European Heart Journal, 42(30), pp. 2951-2952. (doi: 10.1093/eurheartj/ehab238) (PMID:34166487)

Rawshani, A. et al. (2021) Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: a nationwide retrospective cohort study. Lancet Regional Health - Europe, 4, 100105. (doi: 10.1016/j.lanepe.2021.100105) (PMID:33969336) (PMCID:PMC8086507)

Kuriakose, J., Montezano, A. C. and Touyz, R. M. (2021) ACE-2/Ang (1-7)/Mas axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clinical Science, 135(2), pp. 387-407. (doi: 10.1042/CS20200480) (PMID:33511992) (PMCID:PMC7846970)

Briscoe, M., Sykes, R. , Krystofiak, T., Peck, O., Mangion, K. and Berry, C. (2021) Clinical significance of coronavirus disease 2019 in hospitalized patients with myocardial injury. Clinical Cardiology, 44(3), pp. 332-339. (doi: 10.1002/clc.23530) (PMID:33501708) (PMCID:PMC7943910)

Hastie, C. , Pell, J. and Sattar, N. (2021) Vitamin D and COVID-19 infection and mortality in UK Biobank. European Journal of Nutrition, 60, pp. 545-548. (doi: 10.1007/s00394-020-02372-4) (PMID:32851419) (PMCID:PMC7449523)

McPeake, J. et al. (2021) Long-term outcomes following severe COVID-19 infection: a multicentre cohort study of family member outcomes. Annals of the American Thoracic Society, 18(12), pp. 2098-2101. (doi: 10.1513/AnnalsATS.202104-481RL) (PMID:34192506)

McGettrick, M., MacLellan, A., McCaughey, P., Bagot, C., Brewis, M.J., Lang, N.N. , Johnson, M.K. and Church, A.C. (2021) Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland. BMJ Open, 11, e050281. (doi: 10.1136/bmjopen-2021-050281) (PMID:34462282)

Li, K. K. et al. (2021) Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. Journal of Infection, 83(1), pp. 96-103. (doi: 10.1016/j.jinf.2021.04.020) (PMID:33895226) (PMCID:PMC8061788)

Hewitt, J. et al. (2020) The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health, 5(8), e444-e451. (doi: 10.1016/S2468-2667(20)30146-8) (PMID:32619408) (PMCID:PMC7326416)

Guzik, T. J. et al. (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research, 116(10), pp. 1666-1687. (doi: 10.1093/cvr/cvaa106) (PMID:32352535) (PMCID:PMC7197627)

Murray, E. , Tomaszewski, M. and Guzik, T. J. (2020) Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications. Cardiovascular Research, 116(7), e87-e89. (doi: 10.1093/cvr/cvaa096) (PMID:32301968) (PMCID:PMC7184453)

Al-Ozairi, E. et al. (2021) Risk of mortality among inpatients with COVID-19 and type 2 diabetes: national data from Kuwait. Endocrinology, Diabetes and Metabolism, 4(4), e00287. (doi: 10.1002/edm2.287) (PMID:34505420) (PMCID:PMC8420596)

Pellicori, P. et al. (2021) COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, 2021(3), CD013879. (doi: 10.1002/14651858.CD013879) (PMID:33704775)

MacTavish, P., McPeake, J. , Breslin, A., Forrest, R., Kishore, R., MacGregor, F., Oprey, A., Quasim, T. and Shaw, M. (2021) Evaluation of medication changes following severe COVID-19 infection: a multicentre evaluation. BMJ Open Respiratory Research, 8(1), e001037. (doi: 10.1136/bmjresp-2021-001037)

Caiazzo, E., Rezig, A. O.M., Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F. , Guzik, T. J., Maffia, P. and Pellicori, P. (2021) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, (doi: 10.1016/j.phrs.2021.106053) (PMID:34979235) (In Press)

Sullivan, M. K. et al. (2021) Acute kidney injury in patients hospitalised with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfab303) (PMID:34661677) (Early Online Publication)

Lim, A. et al. (2020) An international report on the adaptations of rapid transient ischaemic attack pathways during the COVID-19 pandemic. Journal of Stroke and Cerebrovascular Diseases, 29(11), 105228. (doi: 10.1016/j.jstrokecerebrovasdis.2020.105228) (PMID:33066882) (PMCID:PMC7434484)

Touyz, R. M. et al. (2021) Cardiovascular and renal risk factors and complications associated with COVID-19. CJC Open, 3(10), pp. 1257-1272. (doi: 10.1016/j.cjco.2021.05.020) (PMID:34151246) (PMCID:PMC8205551)

Ho, F. K. et al. (2020) Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study. BMJ Open, 10, e040402. (doi: 10.1136/bmjopen-2020-040402) (PMID:33444201) (PMCID:PMC7678347)

Petermann-Rocha, F. et al. (2020) Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank. BMC Medicine, 18, 355. (doi: 10.1186/s12916-020-01822-4) (PMID:33167965) (PMCID:PMC7652674)

Wolf, F. I. et al. (2021) The magnesium global network (MaGNet) to promote research on magnesium in diseases focusing on covid-19. Magnesium Research, 34(2), pp. 90-92. (doi: 10.1684/mrh.2021.0479) (PMID:34524085)

Geriatric Medicine Research Collaborative, et al. (2021) Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study. Age and Ageing, 50(3), pp. 617-630. (doi: 10.1093/ageing/afab026) (PMID:33543243) (PMCID:PMC7929433)

Niedzwiedz, C. L. et al. (2020) Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Medicine, 18, 160. (doi: 10.1186/s12916-020-01640-8) (PMID:32466757) (PMCID:PMC7255908)

McQueenie, R. et al. (2020) Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS ONE, 15(8), e0238091. (doi: 10.1371/journal.pone.0238091) (PMID:32817712) (PMCID:PMC7440632)

Perry, R. J. et al. (2021) Characteristics and outcomes of COVID-19-associated stroke: a UK multicentre case-control study. Journal of Neurology, Neurosurgery and Psychiatry, 92(3), pp. 242-248. (doi: 10.1136/jnnp-2020-324927) (PMID:33154179)

Hanratty, B., Burton, J. K. , Goodman, C., Gordon, A. L. and Spilsbury, K. (2020) Covid-19 and lack of linked datasets for care homes. British Medical Journal, 369, m2463. (doi: 10.1136/bmj.m2463) (PMID:32581008)

Sigfrid, L. et al. (2021) Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Regional Health - Europe, 8, 100186. (doi: 10.1016/j.lanepe.2021.100186) (PMID:34386785) (PMCID:PMC8343377)

Stock, S. J. et al. (2022) Cohort profile: the Covid-19 in pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancy. International Journal of Epidemiology, (doi: 10.1093/ije/dyab243) (PMID:34977922) (Early Online Publication)

McPeake, J. et al. (2021) Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study. BMJ Open Respiratory Research, 8, e001080. (doi: 10.1136/bmjresp-2021-001080)

Sigfrid, L. et al. (2021) What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open, 11(3), e043887. (doi: 10.1136/bmjopen-2020-043887) (PMID:33692181) (PMCID:PMC7948153)

Sattar, N. and Valabhji, J. (2021) Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for health care. Current Obesity Reports, 10(3), pp. 282-289. (doi: 10.1007/s13679-021-00448-8) (PMID:34374955) (PMCID:PMC8353061)

Bell, S. et al. (2020) COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry. BMC Nephrology, 21, 419. (doi: 10.1186/s12882-020-02061-8) (PMID:33004002) (PMCID:PMC7528715)

Lee, M. M.Y. et al. (2020) Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis. European Heart Journal: Cardiovascular Pharmacotherapy, (doi: 10.1093/ehjcvp/pvaa138) (PMID:33337478) (PMCID:PMC7799280) (Early Online Publication)

Anderson, J. J. et al. (2021) Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study. Journal of Thrombosis and Haemostasis, 19(10), pp. 2533-2538. (doi: 10.1111/jth.15452) (PMID:34242477) (PMCID:PMC8420476)

Willder, J. M., McCall, P. , Messow, C.-M. , Gillies, M., Berry, C. and Shelley, B. (2021) Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19. BMJ Open, 11(1), e042098. (doi: 10.1136/bmjopen-2020-042098) (PMID:33441361) (PMCID:PMC7811959)

Burton, J. K. et al. (2020) Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK. Lancet Healthy Longevity, 1(1), E21-E31. (doi: 10.1016/S2666-7568(20)30012-X) (PMID:PMC7574931)

Adão, R. and Guzik, T. J. (2020) Inside the heart of COVID-19. Cardiovascular Research, 116(6), (doi: 10.1093/cvr/cvaa086) (PMID:32266937)

Holman, N. et al. (2020) Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes and Endocrinology, 8(10), pp. 823-833. (doi: 10.1016/S2213-8587(20)30271-0) (PMID:32798471) (PMCID:PMC7426091)

Hastie, C. E. et al. (2020) Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(4), pp. 561-565. (doi: 10.1016/j.dsx.2020.04.050) (PMID:32413819) (PMCID:PMC7204679)

Jani, B. D. , Ho, F. K., Lowe, D. J. , Traynor, J. P., MacBride-Stewart, S. P., Mark, P. B. , Mair, F. S. and Pell, J. P. (2021) Comparison of COVID-19 outcomes among shielded and non-shielded populations. Scientific Reports, 11, 15278. (doi: 10.1038/s41598-021-94630-6) (PMID:34315958) (PMCID:PMC8316565)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)

Carter, B. et al. (2020) Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial study (COVID in Older PEople). Journal of Hospital Infection, 106(2), pp. 376-384. (doi: 10.1016/j.jhin.2020.07.013) (PMID:32702463) (PMCID:PMC7372282)

Jacob, J. et al. (2020) Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database. European Respiratory Journal, 56(2), 2001809. (doi: 10.1183/13993003.01809-2020) (PMID:32616598) (PMCID:PMC7331656)

Sattar, N. et al. (2020) BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(5), pp. 1149-1151. (doi: 10.1016/j.dsx.2020.06.060) (PMID:32668401) (PMCID:PMC7326434)

O’Sullivan, E. D., Lees, J. S. , Howie, K. L., Pugh, D., Gillis, K. A. , Traynor, J. P., Macintyre, I. and Mark, P. B. (2021) Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease. Nephrology, 26(4), pp. 328-332. (doi: 10.1111/nep.13844) (PMID:33368892)

Drake, T. M. et al. (2021) Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet, 398(10296), pp. 223-237. (doi: 10.1016/S0140-6736(21)00799-6) (PMID:34274064) (PMCID:PMC8285118)

Petrie, J. R. , Boyle, J. G., Ali, K., Smith, C., Morrison, D. and Kar, P. (2020) A post COVID‐19 ‘Marshall Plan’ for type 2 diabetes. Diabetic Medicine, (doi: 10.1111/dme.14439)

Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J.V. , Pfeffer, M. A. and Solomon, S. D. (2020) Renin–Angiotensin–Aldosterone System inhibitors in patients with Covid-19. New England Journal of Medicine, 382(17), pp. 1653-1659. (doi: 10.1056/nejmsr2005760) (PMID:32227760)

Richardson, S. J. et al. (2020) Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities. Age and Ageing, 49(6), pp. 901-906. (doi: 10.1093/ageing/afaa149) (PMID:32584954) (PMCID:PMC7454250)

Harrison, E. M. et al. (2020) Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. SSRN Electronic Journal, (doi: 10.2139/ssrn.3618215) (Submitted)

Boyle, J. G., Walters, M. R. , Jamieson, S. and Durning, S. J. (2020) Clinical reasoning in the wild: premature closure during the COVID-19 pandemic. Diagnosis, 7(3), pp. 177-179. (doi: 10.1515/dx-2020-0061) (PMID:32710716)

Zuber, V., Cameron, A., Myserlis, E. P., Bottolo, L., Fernandez‐Cadenas, I., Burgess, S., Anderson, C. D., Dawson, J. and Gill, D. (2021) Leveraging genetic data to elucidate the relationship between COVID‐19 and ischemic stroke. Journal of the American Heart Association, 10(22), e022433. (doi: 10.1161/JAHA.121.022433) (PMID:34755518)

Mutambudzi, M. et al. (2021) Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine, 78(5), pp. 307-314. (doi: 10.1136/oemed-2020-106731) (PMID:33298533)

Ho, F. K. et al. (2020) Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE, 15(11), e0241824. (doi: 10.1371/journal.pone.0241824) (PMID:33152008) (PMCID:PMC7644030)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Delles, C. , Li, H. and Touyz, R. M. (2020) ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. Clinical Science, 134(7), pp. 747-750. (doi: 10.1042/CS20200363)

Stevens, K., Melilli, E., Diniz, H., Gillis, K. , Guerrot, D., Montero, N., Soler, M. J. and Desai, T. (2021) Tweet me: conferencing in the era of COVID-19 and 280 characters. Clinical Kidney Journal, 14(10), pp. 2142-2150. (doi: 10.1093/ckj/sfab075) (PMID:34603691) (PMCID:PMC8083586)

Psotka, M. A. et al. (2020) Conduct of clinical trials in the era of COVID-19: JACC scientific expert panel. Journal of the American College of Cardiology, 76(20), pp. 2368-2378. (doi: 10.1016/j.jacc.2020.09.544) (PMID:33183511)

Khunti, K. et al. (2021) Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes and Endocrinology, 9(5), pp. 293-303. (doi: 10.1016/S2213-8587(21)00050-4) (PMID:33798464) (PMCID:PMC8009618)

Jani, B. D. et al. (2021) Family history of diabetes and risk of SARS-COV-2 in UK Biobank: a prospective cohort study. Endocrinology, Diabetes and Metabolism, 4(4), e00283. (doi: 10.1002/edm2.283) (PMID:34505416) (PMCID:PMC8420405)

Zhang, P. et al. (2020) Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation Research, 126(12), pp. 1671-1681. (doi: 10.1161/circresaha.120.317134) (PMID:32302265) (PMCID:PMC7265882)

McPeake, J. , Henderson, P., MacTavish, P. and Quasim, T. (2021) Provision of holistic care after severe COVID-19 pneumonia. Lancet Respiratory Medicine, 9(3), e24. (doi: 10.1016/S2213-2600(21)00019-9) (PMID:33556320) (PMCID:PMC7906750)

Evans, P. C. et al. (2020) Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovascular Research, 116(14), pp. 2177-2184. (doi: 10.1093/cvr/cvaa230) (PMID:32750108) (PMCID:PMC7454368)

Sabir, S. R., Thomson, E. C. , Guzik, T. J., D’Acquisto, F. and Maffia, P. (2020) COVID-19: the new immune challenge. Frontiers for Young Minds, 8, 582971. (doi: 10.3389/frym.2020.582971)

Mahindra, A. et al. (2021) Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction. PLoS ONE, 16(11), e0260283. (doi: 10.1371/journal.pone.0260283) (PMID:34793553) (PMCID:PMC8601423)

Collins, J. T. et al. (2020) The clinical frailty scale: estimating the prevalence of frailty in older patients hospitalised with COVID-19. The COPE study. Geriatrics, 5(3), 58. (doi: 10.3390/geriatrics5030058) (PMID:32967236) (PMCID:PMC7554723)

Barron, E. et al. (2020) Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes and Endocrinology, 8(10), pp. 813-822. (doi: 10.1016/S2213-8587(20)30272-2) (PMID:32798472) (PMCID:PMC7426088)

Meek, C.L., Lindsay, R.S. , Scott, E.M., Aiken, C.E., Myers, J., Reynolds, R.M., Simmons, D., Yamamoto, J.M., McCance, D.R. and Murphy, H.R. (2021) Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic. Diabetic Medicine, 38(1), e14380. (doi: 10.1111/dme.14380) (PMID:32750184) (PMCID:PMC7436759)

Sattar, N. , McInnes, I. B. and McMurray, J. J.V. (2020) Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation, 142(1), pp. 4-6. (doi: 10.1161/CIRCULATIONAHA.120.047659) (PMID:32320270)

Ho, F. K., Man, K. K.S., Toshner, M., Church, C., Celis-Morales, C. , Wong, I. C.K., Berry, C. , Sattar, N. and Pell, J. P. (2021) Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: a self-controlled case series analysis of a nation-wide cohort. Mayo Clinic Proceedings, 96(10), pp. 2587-2597. (doi: 10.1016/j.mayocp.2021.07.002) (PMID:34607634) (PMCID:PMC8282478)